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Methodology and Results  
The Codex Alimentarius specifies in Codex Standard 118-1979 (2008) the R5 antibody based ELISA as the standard method for the determination of gluten, allowing for the detection of α-, β-, γ- e ω-
prolamins. In this study we evaluated the gluten content of 51 samples (2010-2015) using the Sandwich R5-ELISA (RIDASCREEN® Gliadin) in conjunction with a cocktail solution, that allows for extraction 
of wheat, barley and rye prolamins from both unheated and heated foods.  
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Table 1. Analytical limits of Sandwich R5-ELISA method. 
Analytical Limits 
Limit of Detection 3 mg/Kg 
Limit of Quantification 5 mg/Kg 
Conclusion  
In samples obtained from the Food Industry, the results, below the limit of detection, showed that all of the samples can be safely labelled as “Gluten-free”. Regarding the monitoring program, the results are in agreement with the 
information “Gluten-free” inserted on the labels, as all the samples contained levels of gluten below 20 mg/Kg.  
This study underlines the importance of the laboratory in ensuring that the information “gluten-free” on the labels is reliable, so people with CD can make informed choices about the products available on the market. 
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Aims 
The aims of this work were to evaluate the conformity of labelling, connected with gluten-free information, and to carry out analysis for detection and quantification of gluten in 
foodstuffs from food industry, so that reliable information can be inserted on the labels. 
Food safety continues to mobilize all aspects of the food chain, from traders to consumers. Thus, labelling has proved to be an important tool during the buying decision: the label is the first link between 
the product and consumers. Providing them with relevant information about the product, allow them to make conscious, healthy and safe choices, especially those suffering from food allergies or 
intolerances. 
Celiac disease (CD) is a chronic small intestinal immune-mediated enteropathy precipitated by exposure to dietary gluten in genetically susceptible individuals, hampering macro and micro nutrients 
absorption. It has not been possible until now to establish an acceptable daily intake of gluten that can be tolerated by people with celiac disease, which treatment currently consists of a gluten-free diet 
(GFD) throughout life. 
In the last years, the impressive growth of CD incidence, significantly provoked changes in the dietary habit of an increasingly large population, with a rise in demand of gluten-free products. GFD is a 
complex and challenging diet but recent advances in the food industry are making it easier to follow. 
Although several advances have been made in the preparation processes of gluten-free products, many of them, available on the market, exhibit a low nutritional quality. Previous studies have 
demonstrated that these products are poor sources of minerals, vitamins and fibre; therefore, its nutritional content is an increasing area of concern.  
In addition, patients with CD tend to compensate the restrictions of a GFD by eating foods containing high levels of fat, salt, sugars and calories, leading to the risk of developing obesity and diseases 
related to the metabolic syndrome. Therefore, getting nutritional therapy should be an essential part of this complex disease. 
Currently, shopping for commercial gluten-free products is less difficult than in the past, but still risky for those particularly sensitive to gluten because many foods aren’t labelled accurately or consistently. 
In accordance with the European Regulation No 1169/2011, which came into force on 13 December 2014, it’s mandatory to include the substances or products that cause allergies or intolerances on the 
label. At European level there is a great concern with this type of food intolerance, therefore foodstuffs intended for particular nutritional use have a specific regulation (No 41/2009). This regulation, 
applicable since January of 2012, concerns the composition and labelling of foodstuffs suitable for people with gluten intolerance. 
In order to comply with this Regulation and to insert reliable information on food labels, the Food and Nutrition Department’s Chemistry laboratory, works with the food industry and carry out analysis for 
detection and quantification of gluten in food and raw materials. The laboratory has also collaborated with an Association of Support for celiac patients, in a food monitoring program intended for 
particular nutritional uses, in order to evaluate food products labelled "gluten-free“. 
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Meat products Sugar-based products Beverages 
Composite dishes Cereal products  
Table 2.  Results of gluten analysis. 
Food groups Gluten results (mg/Kg) 
Meat products < 3 
Sugar-based products < 3 
Beverages < 3 
Composite dishes < 3 
Cereal products  < 20 
